Profund Advisors’s Krystal Biotech KRYS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.12M | Buy |
8,166
+2,203
| +37% | +$303K | 0.04% | 277 |
|
2025
Q1 | $1.08M | Sell |
5,963
-358
| -6% | -$64.5K | 0.05% | 280 |
|
2024
Q4 | $990K | Sell |
6,321
-3,664
| -37% | -$574K | 0.04% | 301 |
|
2024
Q3 | $1.82M | Buy |
9,985
+1,292
| +15% | +$235K | 0.07% | 207 |
|
2024
Q2 | $1.6M | Buy |
8,693
+140
| +2% | +$25.7K | 0.06% | 215 |
|
2024
Q1 | $1.52M | Sell |
8,553
-5,229
| -38% | -$930K | 0.06% | 224 |
|
2023
Q4 | $1.71M | Buy |
13,782
+1,542
| +13% | +$191K | 0.07% | 203 |
|
2023
Q3 | $1.42M | Buy |
12,240
+2,375
| +24% | +$276K | 0.08% | 202 |
|
2023
Q2 | $1.16M | Sell |
9,865
-1,716
| -15% | -$201K | 0.06% | 283 |
|
2023
Q1 | $927K | Buy |
+11,581
| New | +$927K | 0.06% | 320 |
|